You are viewing the site in preview mode
Skip to main content
| |
DM (n = 149)
|
Non-DM (n = 188)
|
p value
|
|---|
|
At the time of PCI
|
|
Aspirin, n (%)
|
139 (93)
|
173 (92)
|
0.41
|
|
Clopidogrel, n (%)
|
73 (49)
|
112 (60)
|
0.061
|
|
Prasugrel, n (%)
|
52 (35)
|
53 (28)
|
0.20
|
|
Ticlopidine, n (%)
|
7 (5)
|
8 (4)
|
1.0
|
|
Statin, n (%)
|
80 (54)
|
92 (49)
|
0.22
|
|
Insulin, n (%)
|
24 (16)
|
0 (0)
|
N/A
|
|
Biguanide, n (%)
|
38 (26)
|
0 (0)
|
N/A
|
|
DPP-4 inhibitor, n (%)
|
59 (40)
|
0 (0)
|
N/A
|
|
SGLT-2 inhibitor, n (%)
|
4 (3)
|
0 (0)
|
N/A
|
|
Thiazolidine, n (%)
|
18 (12)
|
0 (0)
|
N/A
|
|
Sulfonylurea, n (%)
|
39 (26)
|
0 (0)
|
N/A
|
|
Glinide, n (%)
|
6 (4)
|
0 (0)
|
N/A
|
|
α-glucosidase inhibitor, n (%)
|
26 (17)
|
0 (0)
|
N/A
|
|
At the time of CAS evaluation
|
|
Aspirin, n (%)
|
149 (100)
|
186 (99)
|
0.31
|
|
Clopidogrel, n (%)
|
79 (53)
|
104 (55)
|
0.74
|
|
Prasugrel, n (%)
|
63 (42)
|
64 (34)
|
0.14
|
|
Ticlopidine, n (%)
|
6 (4)
|
8 (4)
|
1.0
|
|
Statin, n (%)
|
102 (69)
|
142 (76)
|
0.094
|
|
Insulin, n (%)
|
25 (17)
|
0 (0)
|
N/A
|
|
Biguanide, n (%)
|
43 (29)
|
0 (0)
|
N/A
|
|
DPP-4 inhibitor, n (%)
|
62 (42)
|
0 (0)
|
N/A
|
|
SGLT-2 inhibitor, n (%)
|
5 (3)
|
0 (0)
|
N/A
|
|
Thiazolidine, n (%)
|
18 (12)
|
0 (0)
|
N/A
|
|
Sulfonylurea, n (%)
|
40 (27)
|
0 (0)
|
N/A
|
|
Glinide, n (%)
|
10 (7)
|
0 (0)
|
N/A
|
|
α-glucosidase inhibitor, n (%)
|
31 (21)
|
0 (0)
|
N/A
|
- Data are presented as number (%)
- CAS coronary angioscopy, DM diabetes mellitus, DPP-4 dipeptidyl peptidase-4, N/A not available, SGLT-2 sodium glucose cotransporter-2
